2,057 results on '"Dewhirst, Mark"'
Search Results
52. Supplementary Data from Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy
53. Supplementary Figure S1 Legend from Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials
54. Supplementary Figures S1-S3; Tables S1, S2 from Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
55. Data from Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy
56. Supplementary Figure Legend from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma
57. Supplementary Figures S1-S7 from Comparison of Genomics and Functional Imaging from Canine Sarcomas Treated with Thermoradiotherapy Predicts Therapeutic Response and Identifies Combination Therapeutics
58. Data from Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data
59. Supplementary Movie 3 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
60. Supplementary Figure and Table Legends from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
61. Supplementary Movie 5 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
62. Supplementary Figure 1 from Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
63. Supplementary Materials and Figure Legend from Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
64. Supplementary Movie 1 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
65. Supplementary Video 2 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
66. Supplementary Movie 9 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
67. Supplementary Movie 7 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
68. Data from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
69. GO term analysis from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
70. Data from Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
71. Supplementary Table 1 from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
72. Supplementary Figures 1-2 from Systemic Overexpression of Angiopoietin-2 Promotes Tumor Microvessel Regression and Inhibits Angiogenesis and Tumor Growth
73. Supplementary Video 1 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
74. Supplementary Table 2 from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
75. Supplementary Table 3 from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
76. Supplementary Materials and Methods from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
77. Supplementary Movie 2 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
78. Supplementary Movie 4 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
79. Data from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
80. Supplementary Figure Legends from Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
81. Supplementary Legends for Figure 1,Tables 1-2 and Movies 1-9 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
82. Supplementary Table 2 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
83. Supplementary Figures from Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
84. Supplementary Movie 8 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
85. Data from Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors
86. Supplementary Figure 1 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
87. Supplementary Methods and Materials from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
88. Supplementary Table 1 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
89. Supplementary Figure 1 Legend from Development of Magnetic Resonance Imaging Contrast Material for In vivo Mapping of Tissue Transglutaminase Activity
90. Supplementary Figures 1-5 from Estrogen-Related Receptor α Is Critical for the Growth of Estrogen Receptor–Negative Breast Cancer
91. Supplementary Figure 1 from Development of Magnetic Resonance Imaging Contrast Material for In vivo Mapping of Tissue Transglutaminase Activity
92. Supplementary Figure 1 from Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors
93. Supplementary Movie 6 from The Pervasive Presence of Fluctuating Oxygenation in Tumors
94. Hyperbaric Oxygen Improves Tumor Radiation Response Significantly More Than Carbogen/Nicotinamide
95. Abstract P3-08-06: Monitoring Lymphovascular Invasion and Tumor Growth of Inflammatory Breast Cancer in a Murine Lymphatic Reporter Window Chamber Model
96. Transport of drugs from blood vessels to tumour tissue
97. A Clinical Study to Assess Diffuse Reflectance Spectroscopy with an Auto-Calibrated, Pressure-Sensing Optical Probe in Head and Neck Cancer
98. Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer
99. Stroma-Free Human Hemoglobin A Decreases R3230Ac Rat Mammary Adenocarcinoma Blood Flow and Oxygen Partial Pressure
100. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.